Neonatal intestinal obstruction associated with oral calcium supplementation.
D000284:Administration, Oral; D002130:Calcium Phosphates / Q000009:adverse effects*; D005527:Food, Fortified / Q000009:adverse effects*; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000209:etiology*; D007415:Intestinal Obstruction / Q000209:etiology*; D008297:Male
D002130:Calcium Phosphates; C485828:alpha-tricalcium phosphate; C485830:tetracalcium phosphate; C485838:calcium phosphate, monobasic, anhydrous; C020243:calcium phosphate; C485829:calcium phosphate, dibasic, anhydrous